King Luther Capital Management Corp boosted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 12.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,704 shares of the semiconductor company’s stock after purchasing an additional 2,977 shares during the period. King Luther Capital Management Corp’s holdings in Synopsys were worth $11,615,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in SNPS. Maryland State Retirement & Pension System grew its position in Synopsys by 12.4% in the third quarter. Maryland State Retirement & Pension System now owns 11,276 shares of the semiconductor company’s stock valued at $4,904,000 after acquiring an additional 1,246 shares during the period. Ritholtz Wealth Management lifted its holdings in shares of Synopsys by 12.7% during the third quarter. Ritholtz Wealth Management now owns 2,056 shares of the semiconductor company’s stock valued at $894,000 after acquiring an additional 232 shares during the period. Machina Capital S.A.S. boosted its stake in shares of Synopsys by 18.8% in the 3rd quarter. Machina Capital S.A.S. now owns 5,887 shares of the semiconductor company’s stock valued at $2,560,000 after purchasing an additional 933 shares in the last quarter. Riverbridge Partners LLC boosted its stake in shares of Synopsys by 23.2% in the 3rd quarter. Riverbridge Partners LLC now owns 69,586 shares of the semiconductor company’s stock valued at $30,266,000 after purchasing an additional 13,105 shares in the last quarter. Finally, Bahl & Gaynor LLC acquired a new stake in shares of Synopsys in the 3rd quarter valued at $365,000. 85.47% of the stock is owned by institutional investors and hedge funds.
Top Synopsys Stories
These are some of the SNPS stories that stood out recently:
- Positive Sentiment: Synopsys is positioning its electronic design automation (EDA) tools for continued demand by adding AI-powered chip design and verification capabilities and integrating Ansys. This could support growth as chip complexity and AI investment rise. Can AI-Driven EDA Accelerate Synopsys’ Next Growth Phase?
- Neutral Sentiment: One article frames Synopsys’ earnings strength against a cautious market tape, suggesting solid company fundamentals are not yet translating into consistently positive investor sentiment. Synopsys (SNPS) Stock Price Prediction: Earnings strength meets a cautious tape
- Negative Sentiment: Despite estimate beats, Synopsys shares have reportedly struggled to hold post-earnings gains. Coverage identifies debt and upcoming guidance as investor concerns ahead of the December earnings report, which could keep the shares volatile. Synopsys at $460: Appealing Ahead of Dec. 8 Earnings
Insider Activity at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 14,604 shares of the business’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the completion of the transaction, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at approximately $35,576,196.60. The trade was a 15.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 24,641 shares of the company’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the transaction, the insider owned 120,443 shares in the company, valued at $50,518,611.92. The trade was a 16.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 117,163 shares of company stock worth $51,366,457 in the last quarter. Insiders own 0.56% of the company’s stock.
Synopsys Price Performance
Synopsys stock opened at $462.69 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The firm has a market cap of $88.67 billion, a P/E ratio of 81.75, a P/E/G ratio of 1.47 and a beta of 1.18. The business’s fifty day moving average is $444.38 and its two-hundred day moving average is $441.35. Synopsys, Inc. has a 52 week low of $362.55 and a 52 week high of $539.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. During the same period last year, the company posted $3.39 earnings per share. The firm’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities research analysts forecast that Synopsys, Inc. will post 11.01 earnings per share for the current fiscal year.
Synopsys declared that its board has authorized a stock repurchase program on Monday, October 5th that authorizes the company to repurchase $1 billion in outstanding shares. This repurchase authorization authorizes the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board of directors believes its stock is undervalued.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on SNPS. Weiss Ratings cut shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, September 11th. Bank of America boosted their price target on shares of Synopsys from $500.00 to $600.00 in a research report on Thursday, October 1st. Morgan Stanley boosted their price target on shares of Synopsys from $500.00 to $574.00 and gave the company an “overweight” rating in a research report on Tuesday, October 20th. BNP Paribas Exane upped their price objective on shares of Synopsys from $420.00 to $475.00 and gave the stock a “neutral” rating in a research note on Thursday, October 1st. Finally, Needham & Company LLC raised their price objective on shares of Synopsys from $580.00 to $620.00 and gave the stock a “buy” rating in a report on Monday, October 12th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Synopsys has an average rating of “Moderate Buy” and an average price target of $575.00.
Check Out Our Latest Report on Synopsys
Synopsys Profile
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Further Reading
- Five stocks we like better than Synopsys
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
